Long-term safety of infliximab (INX) with methotrexate (MTX) in a large belgian observational patient cohort with severe, refractory rheumatoid arthritis (RA)

Durez, Patrick;Devogelaer, Jean-Pierre;Vander Cruyssen, B.;Vandenbosch, F.;Westhovens, Rene;et.al.
(2006) Annual European Congress of Rheumatology (EULAR 2006) — Location: Amsterdam (Netherlands) (21.June.2006)

Files

No attached file found for this publication.

Details

Authors
  • Author
  • Devogelaer, Jean-PierreUCLouvain
    Author
  • Vander Cruyssen, B.
    Author
  • Vandenbosch, F.
    Author
  • Westhovens, ReneUCLouvain
    Author
Show more
Affiliations

Citations

Durez, P., Devogelaer, J.-P., Vander Cruyssen, B., Vandenbosch, F., Vastesaeger, N., Geldhof, A., De Keyser, F., Verbruggen, L., De Clerck, L., Peretz, A., Malaise, M., Van Heuverbeke, F., & Westhovens, R. (2006). Long-term safety of infliximab (INX) with methotrexate (MTX) in a large belgian observational patient cohort with severe, refractory rheumatoid arthritis (RA). Annals of the Rheumatic Diseases, 65, 189. https://hdl.handle.net/2078.5/148495 (Original work published 2006)